A five-year, $3.2 million grant from the National Institutes of Health (NIH) will fund a  research project that aims…
Articles by Marisa Wexler, MS
ARINA-1, a nebulized therapy being developed by Renovion for cystic fibrosis (CF) and other chronic inflammatory lung diseases, may…
Rage Biotech, a new company building on research done at leading Australian universities, aims to develop treatments to help people…
NHS England and Vertex Pharmaceuticals have reached an agreement that will allow access to Vertex’s Kaftrio (ivacaftor/tezacaftor/elexacaftor),…
The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Kaftrio (ivacaftor/tezacaftor/elexacaftor)…
Nontuberculous mycobacteria (NTM), a type of infectious bacteria, is able to survive being dried for a full day, a…
Most people in the U.K. are unaware of the challenges faced by people living with cystic fibrosis (CF), according…
The third annual CF FamilyCon, a free and online event that connects people with cystic fibrosis (CF) and…
During COVID-19, the U.K. Cystic Fibrosis Registry is taking steps to further the collection of data on how the…
A potential gene therapy for cystic fibrosis, KB407, is able to induce the expression of normal CFTR protein in…